Data-driven stock valuation

Prenetics Global Ltd (PRE) fair value: what the stock is really worth

We calculate from audited financials what Prenetics Global Ltd is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily, free.

1. Compare price with fair valuebelow fair value = cheap, above = expensive
2. Check the quality50 and up solid, 75 and up strong
3. Watch it or check another stockalert when fair value or trend changes

Check any stock: type a name, ticker or ISIN

Consumer Defensive · US · Market cap $341M · ISIN KYG722451062

At a glance

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

• The price sits above even our optimistic bull case ($4.42). The favourable scenario is already priced in.
• Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts.
• The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
• A fairly wide model range ($2.33 to $4.42) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 23, 2026.

How to read this chart

60‑month range $2.90 – $120.81 · fair‑value band $2.33 – $4.42 · the $24.27 price screens above the $3.53 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Aug 23, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Prenetics Global Ltd (PRE) currently trades at $24.27, while our model-based Fair Value estimate is $3.53, implying the stock looks roughly 587.8% overvalued today. The Quality Score stands at 40/100 (below-average quality), in the Consumer Defensive sector. How firm this estimate is: it rests on 1 models at a data quality of 95/100, which puts the evidence level at low.

Over the trailing twelve months, Prenetics Global Ltd generated revenue of $120M at a net margin of −42.0%. Revenue grew 107.7% year over year. It earns a return on equity of −40.8%. The balance sheet holds a net cash position of $29.9M. Fundamentals as of Aug 23, 2026

Scenario range: $2.33 (bear) to $4.42 (bull), the price of $24.27 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target. The share trades near its 52-week high and 238% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −23% fair-value upside, at −85%, PRE screens richer than that median.

Fair Value models

Each model values the company its own way; the fair value above is the evidence-weighted blend. Evidence (0 to 100) shows how complete a model's inputs are. How we calculate →

Key figures & financial health

Quality Score breakdown

About the company

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand.

Full company description

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Prenetics Global Ltd reported revenue of $92.4M in FY2025 versus $12.5M in FY2021, a compound +64.8%/yr. Reported net income was −$37.7M in FY2025.

PRE screens 588% overvalued. Compare with Nestlé S.A →

Peer Group

Packaged Foods · 649 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Packaged Foods median · lower = cheaper

Context: sector, industry, market

• Is the Financials sector expensive or cheap?
• P/E, EV/EBITDA and margins by industry (reference tables)
• Undervalued stocks: US Stocks
• Valuation of the USA market

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Aug 23, 2026).

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

Discover tools

Frequently asked questions